Abstract | OBJECTIVE: METHODS: RESULTS: In total, 111 women were included in the study. A single-dose regimen was effective for 73 (65.8%) women. The overall success rate, including repeat doses, was 73.0% (81/111). There were no significant differences in treatment success between women with missed abortion and those with incomplete abortion (56/89 [62.9%] vs 18/22 [81.8%]; P=0.152). Anteverted uterine position was associated with significantly higher success rates compared with diverging position (62/86 [72.1%] vs 4/18 [22.2%]; P=0.001). CONCLUSION:
Misoprostol is an effective treatment for early pregnancy failure. Uterine position might impact the success of medical treatment for missed abortion.
|
Authors | Philipp Reif, Carmen Tappauf, Thomas Panzitt, Josef Haas, Uwe Lang, Philipp Klaritsch |
Journal | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
(Int J Gynaecol Obstet)
Vol. 121
Issue 2
Pg. 137-40
(May 2013)
ISSN: 1879-3479 [Electronic] United States |
PMID | 23419998
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Abortifacient Agents, Nonsteroidal
- Misoprostol
|
Topics |
- Abortifacient Agents, Nonsteroidal
(administration & dosage, therapeutic use)
- Abortion, Incomplete
(drug therapy)
- Abortion, Missed
(drug therapy)
- Adult
- Cohort Studies
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Humans
- Misoprostol
(administration & dosage, therapeutic use)
- Pregnancy
- Retrospective Studies
- Treatment Outcome
- Uterus
(metabolism)
|